147 related articles for article (PubMed ID: 8594994)
41. Lack of association between endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) polymorphisms in a Japanese population.
Deguchi M; Yoshida S; Kennedy S; Ohara N; Motoyama S; Maruo T
J Soc Gynecol Investig; 2005 Apr; 12(3):208-13. PubMed ID: 15784508
[TBL] [Abstract][Full Text] [Related]
42. Relationship between polymorphism of N-acetyltransferase gene and susceptibility to colorectal carcinoma in a Chinese population.
Lee EJ; Zhao B; Seow-Choen F
Pharmacogenetics; 1998 Dec; 8(6):513-7. PubMed ID: 9918135
[TBL] [Abstract][Full Text] [Related]
43. Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes.
Habil MR; Salazar-González RA; Doll MA; Hein DW
Arch Toxicol; 2022 Nov; 96(11):2999-3012. PubMed ID: 36040704
[TBL] [Abstract][Full Text] [Related]
44. Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli.
Hickman D; Palamanda JR; Unadkat JD; Sim E
Biochem Pharmacol; 1995 Aug; 50(5):697-703. PubMed ID: 7669073
[TBL] [Abstract][Full Text] [Related]
45. Adverse effects of sulfasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene.
Tanaka E; Taniguchi A; Urano W; Nakajima H; Matsuda Y; Kitamura Y; Saito M; Yamanaka H; Saito T; Kamatani N
J Rheumatol; 2002 Dec; 29(12):2492-9. PubMed ID: 12465141
[TBL] [Abstract][Full Text] [Related]
46. N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.
Kamel AM; Ebid GT; Moussa HS
Tumour Biol; 2015 Aug; 36(8):6341-8. PubMed ID: 25804798
[TBL] [Abstract][Full Text] [Related]
47. N-Acetyltransferase-2 (NAT2) genotype frequency among Jordanian volunteers.
Jarrar YB; Ismail S; Irshaid YM
Int J Clin Pharmacol Ther; 2010 Oct; 48(10):688-94. PubMed ID: 20875375
[TBL] [Abstract][Full Text] [Related]
48. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.
Cascorbi I; Drakoulis N; Brockmöller J; Maurer A; Sperling K; Roots I
Am J Hum Genet; 1995 Sep; 57(3):581-92. PubMed ID: 7668286
[TBL] [Abstract][Full Text] [Related]
49. N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital.
Oqal MK; Mustafa KN; Irshaid YM
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1007-10. PubMed ID: 22731637
[TBL] [Abstract][Full Text] [Related]
50. Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations.
Deloménie C; Sica L; Grant DM; Krishnamoorthy R; Dupret JM
Pharmacogenetics; 1996 Apr; 6(2):177-85. PubMed ID: 9156695
[TBL] [Abstract][Full Text] [Related]
51. N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.
Kotila OA; Fawole OI; Olopade OI; Ayede AI; Falusi AG; Babalola CP
Pharmacogenet Genomics; 2019 Jul; 29(5):106-113. PubMed ID: 30882558
[TBL] [Abstract][Full Text] [Related]
52. The structure and characteristics of a fourth allele of polymorphic N-acetyltransferase gene found in the Japanese population.
Abe M; Deguchi T; Suzuki T
Biochem Biophys Res Commun; 1993 Mar; 191(3):811-6. PubMed ID: 8466518
[TBL] [Abstract][Full Text] [Related]
53. Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A.
Dandara C; Masimirembwa CM; Magimba A; Kaaya S; Sayi J; Sommers DK; Snyman JR; Hasler JA
Pharmacogenetics; 2003 Jan; 13(1):55-8. PubMed ID: 12544513
[TBL] [Abstract][Full Text] [Related]
54. Genotyping of the arylamine N-acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim-sulfamethoxazole in infants.
Zielińska E; Niewiarowski W; Bodalski J; Rebowski G; Skretkowicz J; Mianowska K; Sekulska M
Pharm World Sci; 1998 Jun; 20(3):123-30. PubMed ID: 9618736
[TBL] [Abstract][Full Text] [Related]
55. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients.
Agúndez JA; Ladero JM; Olivera M; Abildúa R; Román JM; Benítez J
Oncology; 1995; 52(1):7-11. PubMed ID: 7800347
[TBL] [Abstract][Full Text] [Related]
56. Correlation between NAT2 gene polymorphism and cirrhotic portal hypertension in the Chinese population.
Li XP; Liu Y; Zhang CQ
Genet Test Mol Biomarkers; 2015 Mar; 19(3):138-43. PubMed ID: 25574899
[TBL] [Abstract][Full Text] [Related]
57. Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients.
Risch A; Smelt V; Lane D; Stanley L; van der Slot W; Ward A; Sim E
Pharmacol Toxicol; 1996 Apr; 78(4):235-40. PubMed ID: 8861781
[TBL] [Abstract][Full Text] [Related]
58.
Allen CE; Doll MA; Hein DW
Drug Metab Dispos; 2017 Dec; 45(12):1276-1281. PubMed ID: 29018032
[TBL] [Abstract][Full Text] [Related]
59. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: application to metabolic epidemiology.
Lin HJ; Han CY; Lin BK; Hardy S
Am J Hum Genet; 1993 Apr; 52(4):827-34. PubMed ID: 8460648
[TBL] [Abstract][Full Text] [Related]
60. Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype.
O'Neil WM; Drobitch RK; MacArthur RD; Farrough MJ; Doll MA; Fretland AJ; Hein DW; Crane LR; Svensson CK
Pharmacogenetics; 2000 Mar; 10(2):171-82. PubMed ID: 10762005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
